Newsroom

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...

FRAMINGHAM, Mass. & ROSEBURG, Ore.--(BUSINESS WIRE)--Solar-plus-storage system offsets 100 percent of RUSA's Main Office electricity use and strengthens power reliability for wastewater operations....

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that its partner, Pierre Fabre Pharmaceuticals, Inc. (PFP), has received acceptance by the U.S. Food and Drug Administration (FDA) of the Biologics License Application (BLA) resubmission for tabelecleucel,...

SWINDON, United Kingdom--(BUSINESS WIRE)--Sensata Technologies (NYSE: ST), today announced its brake force sensors are now enabling electromechanical braking (EMB) systems in leading electric vehicles. This milestone marks a significant step in the transition from traditional hydraulic braking to fully electric, brake-by-wire systems, as vehicle OEMs increasingly adopt architectures designed for electrification, autonomy, and software-defined control. Electromechanical brakes represent a shift...

BOSTON--(BUSINESS WIRE)--Delve Detect Plasma enables unbiased detection of more than 68,000 bacteria, fungi, DNA and RNA viruses, and parasites with next-day results...

DUBLIN--(BUSINESS WIRE)--B-Secur and Beacon Hospital Research Institute launch clinical pilot to bring ECG data from any consumer wearable directly into the clinical workflow....

BOSTON--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ: HYFT) (“MindWalk” or the “Company”), a Bio-Native AI company, today announced three senior appointments that strengthen its Boston-based development leadership as the Company’s pipeline advances toward preclinical efficacy studies. Zachary Maben, PhD, joins as Director, Antigen Discovery & Protein Engineering, from Arbor Biotechnologies and previously Pfizer. Joanne Lim, PhD, joins as Director, Preclinical Development, from Orum Ther...

TACOMA, Wash.--(BUSINESS WIRE)--TrueBlue (NYSE: TBI), a leading provider of specialized workforce solutions, announced today that Taryn Owen, President and CEO, and Jill Quinn, SVP and President of TrueBlue’s Centerline and Skilled Trades, have been named to Staffing Industry Analysts’ (SIA) 2026 Global Power 150 Women in Staffing list. The annual list recognizes influential women leaders who are shaping the future of the global staffing industry and broader workforce solutions ecosystem. “Tary...

TRUTH OR CONSEQUENCES, N.M.--(BUSINESS WIRE)--Virgin Galactic (NYSE: SPCE), a leader in commercial spaceflight and advanced aerospace technology, today announced a Cooperative Research and Development Agreement (CRADA) with the Air Force Research Laboratory's (AFRL) Space Warfare Directorate at Kirtland Air Force Base, New Mexico — the Department of the Air Force's primary organization for space environment research and technology development. The 24-month agreement will explore the use of Virg...